Distribution and correlates of serum high-density lipoprotein subclasses (LpA-I and LpA-I:A-II) in children from a biracial community. The bogalusa heart study

Metabolism: Clinical and Experimental

Volumn 47, Issue 6, 1998, Pages 757-763

  Srinivasan, Sathanur R ^a   Elkasabany, Abdalla ^a   Berenson, Gerald S ^a  

^a Tulane Center for Cardiovascular Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL CONTRACEPTIVE AGENT; TRIACYLGLYCEROL;

ADOLESCENT; ALCOHOL CONSUMPTION; ARTICLE; CHILD; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SEXUAL MATURATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031802370     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90042-7     Document Type: Article

References (56)

1. Gordon DJ, Probstfield JL, Garrison RJ, et al: High-density lipoprotein cholesterol and cardiovascular disease: Four prospective American studies. Circulation 79:8-15, 1989
2. Miller GJ, Miller NE: Plasma high density lipoprotein concentration and development of ischemic heart disease. Lancet 1:16-19, 1975
3. Fielding CJ, Fielding PE: Molecular physiology of reverse cholesterol transport. J Lipid Res 36:211-228, 1995
4. Gillum RF: Coronary heart disease in black populations. I. Mortality and morbidity. Am Heart J 104:839-851, 1982
5. Keil JE, Sutherland SE, Hames CG, et al: Coronary disease mortality and risk factors in black and white men. Arch Intern Med 155:1521-1527, 1995
6. Glueck CJ, Gartside P, Laskarzewski PM, et al: High-density lipoprotein cholesterol in blacks and whites: Potential ramifications for coronary heart disease. Am Heart J 108:815-826, 1984
7. Suenram A, Alaupovic P: Isolation of lipoprotein A (Lp-A) and lipoprotein A-I (LpA-I) by immunosorption: Evidence for the lipoprotein heterogeneity of normal human HDL, in Schettler G, Goto I, Hata I, Klose G (eds): Atherosclerosis, vol 4. New York, NY, Springer Verlag, 1997, pp 248-249
8. Brewer HB Jr, Rader DJ: HDL: Structure, function and metabolism. Prog Lipid Res 30:139-144, 1991
9. Fruchart JC, Ailhand G: Apolipoprotein A-containing particles: Physiological role, quantification, and clinical significance. Clin Chem 38:793-797, 1992
10. 125I-labelled lipoproteins with specific polypeptide antisera. Evidence for two populations with differing polypeptide compositions in human high density lipoproteins. Biochemistry 10:3436-3442, 1971
11. Cheung MC, Wolf AC, Lum KD, et al: Distribution and localization of lecithin:holesterol acyltransferase and cholesteryl ester transfer activity in A-I containing lipoproteins. J Lipid Res 27:1135-1144, 1986
12. 2 subfractions with hepatic lipase. J Lipid Res 33:1269-1279, 1992
13. Rader DJ, Castro G, Zech LA, et al: In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I, A-II. J Lipid Res 32:1849-1859, 1991
14. Puchois P, Kandoussi A, Fievet P, et al: Apolipoprotein A-I containing lipoproteins in coronary artery disease. Atherosclerosis 68:35-40, 1987
15. Parra HJ, Arveiler D, Evans AE, et al: A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease: The ECTIM Study. Arterioscler Thromb 12:701-707, 1992
16. Genest JJ, Bard JM, Fruchart JC, et al: Plasma apolipoprotein A-I, A-II, B, E, and C-II containing particles in men with premature coronary artery disease. Atherosclerosis 90:149-157, 1991
17. Berenson GS, McMahan CA, Voors AW, et al: Cardiovascular Risk Factors in Children - The Early Natural History of Atherosclerosis and Essential Hypertension. New York, NY, Oxford University, 1980, pp 1-453
18. Newman WP III, Freedman DS, Voors AW, et al: Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med 314:138-144, 1986
19. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group: Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. JAMA 264:3018-3024, 1990
20. Conference on Blood Lipids in Children: Optimal levels for early prevention of coronary artery disease. Workshop report: Epidemiological section. Prev Med 12:741-797, 1983
21. Steinmetz A, Choukaife A, Visvikis S, et al: Biological factors affecting concentrations of serum LpA-I lipoprotein particles in serum, and determination of reference limits. Clin Chem 36:677-680, 1990
22. Ohta T, Hattori S, Murakami M, et al: Age- and sex-related differences in lipoproteins containing apoprotein A-I. Arteriosclerosis 9:90-95, 1989
23. Bekaest ED, Alaupovic P, Knight-Gibson C, et al: Composition of plasma apoA-I-containing lipoprotein particles in children and adults. Pediatr Res 29:315-321, 1991
24. Tanner JM: Growth at Adolescence (ed 2). Oxford, UK, Blackwell, 1962, pp 1-326
25. Hunter SM, Webber LS, Berenson GS: Cigarette smoking and tobacco usage behavior in children and adolescents: The Bogalusa Heart Study. Prev Med 9:701-712, 1980
26. Rastogi A, Bren ND, Hallaway BJ, et al: Immunomagnetic separation of subpopulation of apolipoprotein A-I. Mayo Clin Proc 69:137-143, 1994
27. Montah A, Vega GL, Grundy SM: Concentration of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia. Arterioscler Thromb 14:511-517, 1994
28. Srinivasan SR, Berenson GS: Serum lipoproteins in children and methods for study, in Lewis LA (ed): CRC Handbook of Electrophoresis, vol 3. Lipoprotein Methodology and Human Studies. Boca Raton, FL, CRC, 1983, pp 185-204
29. Neter J, Wasserman W, Kutner MH (eds): Applied Linear Statistical Models. Homewood, IL, Irwin, 1985, pp 328-376
30. Cheung MC, Albers JJ: Distribution of high density lipoprotein particles with different apoprotein composition: Particles with A-I and A-II and particles with A-I but no A-II. J Lipid Res 23:747-753, 1982
31. Koren E, Puchois P, Alaupovic P, et al: Quantification of two types of apolipoprotein A-I-containing lipoprotein particle in plasma by enzyme-linked differential-antibody immunosorbent assay. Clin Chem 33:38-43, 1987
32. Duverger N, Rader D, Brewer B Jr: Distribution of subclasses of HDL containing apoA-I without apoA-II (LpA-I) in normolipidemic men and women. Arterioscler Thromb 14:1594-1599, 1994
33. Eisenberg S: Plasma lipoprotein conversions: The origin of low-density and high-density lipoproteins. Ann NY Acad Sci 348:30-44, 1980
34. Tyroler HA, Hames CG, Krishan I, et al: Black-white differences in serum lipids and lipoprotein in Evans County. Prev Med 4:541-549, 1975
35. Srinivasan SR, Frerichs RR, Webber LS, et al: Serum lipoprotein profile in children from a biracial community - The Bogalusa Heart Study. Circulation 54:309-318, 1976
36. Srinivasan SR, Freedman DS, Sharma C, et al: Serum apolipoprotein A-I and B in 2854 children from a biracial community: Bogalusa Heart Study. Pediatrics 78:189-200, 1986
37. Srinivasan SR, Freedman DS, Webber LS, et al: Black-white differences in cholesterol levels of serum high-density lipoprotein subclasses among children: The Bogalusa Heart Study. Circulation 76:272-279, 1987
38. Tyroler HA, Heiss G, Schonfeld G, et al: Apolipoproteins A-I, A-II and C-II in black and white residents of Evans County. Circulation 62:249-254, 1980
39. Farris RP, Cresanta JL, Frank GC, et al: Dietary studies of children from a biracial population: Intakes of fat and fatty acids in 10-and 13-year-olds. Am J Clin Nutr 39:114-128, 1984
40. Foster TA, Voors AW, Webber LS, et al: Anthropometric and maturation measurements of children, ages 5-16 years, in a biracial community - The Bogalusa Heart Study. Am J Clin Nutr 30:582-591, 1977
41. Garn SM, Clark DC: Nutrition, growth, development, and maturation: Findings from the Ten-State Nutrition Survey of 1968-1970. Pediatrics 56:306-319, 1975
42. Campaigne BN, Morrison JA, Schumann BC, et al: Indices of obesity and comparisons with previous national survey data in 9- and 10-year-old black and white girls: The National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr 124:675-680, 1994
43. Herman-Giddens ME, Slora EJ, Wasserman RC, et al: Secondary sex characteristics and menses in young girls seen in office practice: A study from the Pediatric Research in Office Setting Network. Pediatrics 99:505-512, 1997
44. Laskarzewski PM, Morrison JA, Gutai J: High and low density lipoprotein cholesterol in adolescent boys: Relationship with endogenous testosterone, estradiol and Quetelet index. Metabolism 32:262-271, 1983
45. Srinivasan SR, Sundaram GS, Williamson GD, et al: Serum lipoproteins and endogenous sex hormones in early life: Observations in children with different lipoprotein profiles. Metabolism 34:861-867, 1985
46. Tikkanen MJ, Nikkila EA: Regulation of hepatic lipase and serum lipoproteins by sex steroids. Am Heart J 113:562-567, 1987
47. Freedman DS, Srinivasan SR, Shear CL, et al: Correlates of high density lipoprotein cholesterol and apolipoprotein A-I levels in children. The Bogalusa Heart Study. Arteriosclerosis 7:354-360, 1987
48. Haffner SM, Applebaum-Bouden D, Wahl PW, et al: Epidemiologic correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II, and D, and lecithin cholesterol acyl transferase. Effects of smoking, alcohol, and adiposity. Arteriosclerosis 5:169-177, 1985
49. Manolio TA, Savage PJ, Burke GL, et al: Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA Study. Arteriosclerosis 10:430-436, 1990
50. Richard F, Marecaux N, Dallongeville J, et al: Effect of smoking cessation on lipoprotein A-I and lipoprotein A-I:A-II levels. Metabolism 46:711-715, 1997
51. Phillips NR, Havel RJ, Kane JP: Serum apolipoprotein A-I levels. Relationship to lipoprotein lipid levels and selected demographic variables. Am J Epidemiol 116:302-313, 1982
52. Tall AR: Plasma cholesteryl ester transfer protein. J Lipid Res 34:1255-1274, 1993
53. McPherson R, Agnani G, Lan P, et al: Role of LpA-I and LpA-I/A-II in cholesteryl ester transfer protein-mediated neutral lipid transfer. Studies in normal subjects and in hypertriglyceridemic patients before and after fenofibrate therapy. Arterioscler Thromb Vasc Biol 16:1340-1346, 1996
54. Rubin EM, Krauss RM, Spangler EA, et al: Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature 353:265-267, 1991
55. Warden CH, Hedrick CC, Qiao JH, et al: Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science 261:469-472, 1993
56. Schultz JR, Verstuyft JG, Gong EL, et al: Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature 365:762-764, 1993